Investing is about picking the right stocks and avoiding the wrong ones. While some companies are capitalizing on powerful ...

Years in the making, the Canadian LP is finding markets closer to the pharmaceutical industry in highly regulated medical cannabis markets.

Investors interested in the marijuana industry will be familiar with Aurora Cannabis (NASDAQ: ACB). This pot grower has been one of the bigger names in the market at least since the end of the last ...

Download the Complete Report Here By Karen Roman Our favorite plug’s strategy is paying off: Net revenue is increasing and ...

Earnings call Aurora Cannabis reported Q1 FY2025 revenue of CAD $83.4M, up 12% YoY, led by 24% growth in international medical cannabis. Adjusted EBITDA rose 87% YoY to CAD $4.9M, and the company ...

After years of being stuck behind the curtain of prohibition, the legal cannabis industry is finally thriving. In October, Canada became the first industrialized country, and the second overall behind ...

Investors in Aurora Cannabis Inc. ACB need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $1.00 Call had some of the highest implied ...

To financially support these growth initiatives, Aurora Cannabis is utilizing an "At-the-Market" (ATM) equity program established in February 2026. This mechanism provides the company with flexible ...

EDMONTON, AB, Feb. 4, 2026 /CNW/ - Aurora Cannabis Inc. (ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 ...

European grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis company EDMONTON, AB, Jan. 20, 2026 /PRNewswire/ - Aurora Cannabis ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-announces-fiscal-2026-third-quarter-results-302678648.html ...